Condorcet Global Opportunity Fund’s AUXILIUM PHARAMCEUTICALS INC AUXL Stock Holding History

Condorcet Global Opportunity Fund’s Portfolio AUXL Stock Details AUXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	$19.7M	Buy	+573,434	New	+$18.7M	8.15%	2

Other funds holding AUXL

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

TAL

TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return

OAM

Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return

Manikay Partners New York $893M AUM 55.39% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Condorcet Global Opportunity Fund's AUXL Position: Q4 2014 in Review

Condorcet Global Opportunity Fund opened a new position in AUXILIUM PHARAMCEUTICALS INC (AUXL) in Q4 2014: 573,434 shares worth $19.7M. The stake represents 8.15% of the portfolio and ranks #2 among its holdings.

158 funds tracked by Wall St. Rank hold AUXL as of Q4 2014.

Condorcet Global Opportunity Fund held 573,434 shares of AUXILIUM PHARAMCEUTICALS INC worth $19.7M as of Q4 2014.
AUXILIUM PHARAMCEUTICALS INC was a new Condorcet Global Opportunity Fund position in Q4 2014.
AUXILIUM PHARAMCEUTICALS INC made up 8.15% of Condorcet Global Opportunity Fund's portfolio in Q4 2014, its #2 holding.
158 funds tracked by Wall St. Rank held AUXILIUM PHARAMCEUTICALS INC as of Q4 2014.

Based on Condorcet Global Opportunity Fund's 13F filing for Q4 2014, filed 17 Feb 2015.